Skip to main content Accessibility help
×
Home

Predicting probability of perirectal colonization with carbapenem-resistant Enterobacteriaceae (CRE) and other carbapenem-resistant organisms (CROs) at hospital unit admission

  • Katherine E. Goodman (a1), Patricia J. Simner (a2), Eili Y. Klein (a1) (a3) (a4), Abida Q. Kazmi (a2), Avinash Gadala (a5), Matthew F. Toerper (a3), Scott Levin (a3), Pranita D. Tamma (a5) (a6), Clare Rock (a5) (a7), Sara E. Cosgrove (a5) (a7), Lisa L. Maragakis (a1) (a5) (a7), Aaron M. Milstone (a1) (a5) (a6), for the CDC Prevention Epicenters Program (a1) (a2) (a3) (a4) (a5) (a6) (a7) and the CDC MIND-Healthcare Program (a1) (a2) (a3) (a4) (a5) (a6) (a7)...

Abstract

Background:

Targeted screening for carbapenem-resistant organisms (CROs), including carbapenem-resistant Enterobacteriaceae (CRE) and carbapenemase-producing organisms (CPOs), remains limited; recent data suggest that existing policies miss many carriers.

Objective:

Our objective was to measure the prevalence of CRO and CPO perirectal colonization at hospital unit admission and to use machine learning methods to predict probability of CRO and/or CPO carriage.

Methods:

We performed an observational cohort study of all patients admitted to the medical intensive care unit (MICU) or solid organ transplant (SOT) unit at The Johns Hopkins Hospital between July 1, 2016 and July 1, 2017. Admission perirectal swabs were screened for CROs and CPOs. More than 125 variables capturing preadmission clinical and demographic characteristics were collected from the electronic medical record (EMR) system. We developed models to predict colonization probabilities using decision tree learning.

Results:

Evaluating 2,878 admission swabs from 2,165 patients, we found that 7.5% and 1.3% of swabs were CRO and CPO positive, respectively. Organism and carbapenemase diversity among CPO isolates was high. Despite including many characteristics commonly associated with CRO/CPO carriage or infection, overall, decision tree models poorly predicted CRO and CPO colonization (C statistics, 0.57 and 0.58, respectively). In subgroup analyses, however, models did accurately identify patients with recent CRO-positive cultures who use proton-pump inhibitors as having a high likelihood of CRO colonization.

Conclusions:

In this inpatient population, CRO carriage was infrequent but was higher than previously published estimates. Despite including many variables associated with CRO/CPO carriage, models poorly predicted colonization status, likely due to significant host and organism heterogeneity.

Copyright

Corresponding author

Author for correspondence: Katherine E. Goodman, Email: Kgoodma7@jhu.edu.

References

Hide All
1.Amit, S, Mishali, H, Kotlovsky, T, Schwaber, MJ, Carmeli, Y. Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors. Clin Microbiol Infect 2015;21:3034.
2.Balkan, II, Aygun, G, Aydin, S, et al. Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival. Int J Infect Dis 2014;26:5156.
3.Ben-David, D, Kordevani, R, Keller, N, et al. Outcome of carbapenem-resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect 2012;18:5460.
4.Falagas, ME, Tansarli, GS, Karageorgopoulos, DE, Vardakas, KZ. Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg Infect Dis 2014;20:11701175.
5.Jamulitrat, S, Arunpan, P, Phainuphong, P. Attributable mortality of imipenem-resistant nosocomial Acinetobacter baumannii bloodstream infection. J Med Assoc Thai= Chotmaihet thangphaet 2009;92:413419.
6.Kumar, SH, De, AS, Baveja, SM, Gore, MA. Prevalence and risk factors of metallo beta-lactamase producing Pseudomonas aeruginosa and Acinetobacter species in burn and surgical wards in a tertiary care hospital. J Lab Physician 2012;4:3942.
7.Biggest antibiotic resistance threats in the United States, 2013. Centers for Disease Control and Prevention website. https://www.cdc.gov/drugresistance/biggest_threats.html. Published 2014. Accessed February 13, 2019.
8.Hong, DJ, Bae, IK, Jang, I-H, Jeong, SH, Kang, H-K, Lee, K. Epidemiology and characteristics of metallo-β-lactamase–producing Pseudomonas aeruginosa. Infect Chemother 2015;47:8197.
9.Kim, UJ, Kim, HK, An, JH, Cho, SK, Park, K-H, Jang, H-C. Update on the epidemiology, treatment, and outcomes of carbapenem-resistant Acinetobacter infections. Chonnam Med J 2014;50:3744.
10.Snitkin, ES, Zelazny, AM, Thomas, PJ, et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med 2012;4(148):148ra116.
11.Tamma, PD, Goodman, KE, Harris, AD, et al. Comparing the outcomes of patients with carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant Enterobacteriaceae bacteremia. Clin Infect Dis 2017;64:257264.
12.Dickstein, Y, Edelman, R, Dror, T, Hussein, K, Bar-Lavie, Y, Paul, M. Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers. J Hosp Infect 2016;94:5459.
13.Giannella, M, Bartoletti, M, Morelli, MC, et al. Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae after liver transplantation: the importance of pre- and posttransplant colonization. Am J Transplant 2015;15:17081715.
14.Macesic, N, Gomez-Simmonds, A, Sullivan, SB, et al. Genomic surveillance reveals diversity of multidrug-resistant organism colonization and infection: a prospective cohort study in liver transplant recipients. Clin Infect Dis 2018;67:905912.
15.Facility guidance for control of carbapenem-resistant Enterobacteriaceae (CRE): November 2015 update. Centers for Disease Control and Prevention website. https://www.cdc.gov/hai/organisms/cre/cre-toolkit/index.html. Published 2015. Accessed February 13, 2019.
16.Shimasaki, T, Segreti, J, Tomich, A, Kim, J, Hayden, MK, Lin, MY. Active screening and interfacility communication of carbapenem-resistant Enterobacteriaceae (CRE) in a tertiary-care hospital. Infect Control Hosp Epidemiol 2018;39:10581062.
17.Goodman, KE, Simner, PJ, Klein, EY, et al. How frequently are hospitalized patients colonized with carbapenem-resistant Enterobacteriaceae (CRE) already on contact precautions for other indications? Infect Control Hosp Epidemiol 2018;39:14911493.
18.Simner, PJ, Martin, I, Opene, B, Tamma, PD, Carroll, KC, Milstone, AM. Evaluation of multiple methods for the detection of gastrointestinal colonization of carbapenem-resistant organisms from rectal swabs. J Clin Microbiol 2016;54:16641667.
19.Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, 28th edition. Supplement M100S. Wayne, PA: CLSI; 2018.
20.Pierce, VM, Simner, PJ, Lonsway, DR, et al. Modified carbapenem inactivation method for phenotypic detection of carbapenemase production among Enterobacteriaceae. J Clin Microbiol 2017;55:23212333.
21.Breiman, L, Friedman, J, Stone, C, Olshen, R. Classification and Regression Trees. Boca Raton, FL: CRC/Chapman & Hall; 1984.
22.Duda, RO, Hart, PE, Stork, DG. Pattern Classification, 2nd edition. New York: Wiley-Interscience; 2001.
23.Roth, JA, Battegay, M, Juchler, F, Vogt, JE, Widmer, AF. Introduction to machine learning in digital healthcare epidemiology. Infect Control Hosp Epidemiol 2018;39:14571462.
24.Woodworth, KR, Walters, MS, Weiner, LM, et al. Vital signs: containment of novel multidrug-resistant organisms and resistance mechanisms—United States, 2006–2017. Morb Mortal Wkly Rep 2018;67:396401.
25.Logan, LK, Weinstein, RA. The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace. J Infect Dis 2017;215 supp 1:S28S36.
26.McKinnell, JA, Miller, LG, Eells, SJ, Cui, E, Huang, SS. A systematic literature review and meta-analysis of factors associated with methicillin-resistant Staphylococcus aureus colonization at time of hospital or intensive care unit admission. Infect Control Hosp Epidemiol 2013;34:10771086.
27.Simner, PJ, Goodman, KE, Carroll, KC, Harris, AD, Han, JH, Tamma, PD. Using patient risk factors to identify whether carbapenem-resistant Enterobacteriaceae infections are caused by carbapenemase-producing organisms. Open Forum Infect Dis 2018;5(5):ofy094.
28.Bhargava, A, Hayakawa, K, Silverman, E, et al. Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients exposed to long-term acute care and acute care facilities. Infect Control Hosp Epidemiol 2014;35:398405.
29.Marchaim, D, Chopra, T, Bhargava, A, et al. Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: the role of antimicrobial stewardship. Infect Control Hosp Epidemiol 2012;33:817830.
30.Predic, M, Delano, JP, Tremblay, E, Iovine, N, Brown, S, Prins C: risk factors for carbapenem-resistant Enterobacteriaceae infection. Am J Infect Control 2017;45(6 Suppl):S14.
31.Torres-Gonzalez, P, Cervera-Hernandez, ME, et al. Factors associated to prevalence and incidence of carbapenem-resistant enterobacteriaceae fecal carriage: a cohort study in a Mexican tertiary care hospital. PloS One 2015;10(10):e0139883.
32.Armand-Lefevre, L, Angebault, C, Barbier, F, et al. Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients. Antimicrob Agents Chemother 2013;57:14881495.
33.Cunha, CB, Kassakian, SZ, Chan, R, et al. Screening of nursing home residents for colonization with carbapenem-resistant Enterobacteriaceae admitted to acute care hospitals: incidence and risk factors. Am J Infect Control 2016;44:126130.
34.Prabaker, K, Lin, MY, McNally, M, et al. Transfer from high-acuity long-term care facilities is associated with carriage of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae: a multihospital study. Infect Control Hosp Epidemiol 2012;33:11931199.
35.Muscarella, LF. Risk of transmission of carbapenem-resistant Enterobacteriaceae and related “superbugs” during gastrointestinal endoscopy. World J Gastrointest Endosc 2014;6:457474.
36.Prasad, N, Labaze, G, Kopacz, J, et al. Asymptomatic rectal colonization with carbapenem-resistant Enterobacteriaceae and Clostridium difficile among residents of a long-term care facility in New York City. Am J Infect Control 2016;44:525532.
37.Huizinga, P, van den Bergh, MK, van Rijen, M, Willemsen, I, van ‘t Veer, N, Kluytmans, J. Proton pump inhibitor use is associated with extended-spectrum beta-lactamase-producing Enterobacteriaceae rectal carriage at hospital admission: a cross-sectional study. Clin Infect Dis 2017;64:361363.
38.D’Agata, EMC, Varu, A, Geffert, SF, et al. Acquisition of multidrug-resistant organisms in the absence of antimicrobials. Clin Infect Dis 2018;67:14371440.
39.Mollenkopf, DF, Stull, JW, Mathys, DA, et al. Carbapenemase-producing Enterobacteriaceae recovered from the environment of a swine farrow-to-finish operation in the United States. Antimicrob Agent Chemother 2017;61(2). doi: 10.1128/AAC.01298-16.
40.Janecko, N, Martz, SL, Avery, BP, et al. Carbapenem-resistant Enterobacter spp. in retail seafood imported from Southeast Asia to Canada. Emerg Infect Dis 2016;22:16751677.
41.Martin, EM, Bryant, B, Grogan, TR, et al. Noninfectious hospital adverse events decline after elimination of contact precautions for MRSA and VRE. Infect Control Hosp Epidemiol 2018;39:788796.
42.Morgan, DJ, Wenzel, RP, Bearman, G. Contact precautions for endemic MRSA and VRE: time to retire legal mandates. JAMA 2017;318:329330.
Type Description Title
WORD
Supplementary materials

Goodman et al. supplementary material
Goodman et al. supplementary material 1

 Word (959 KB)
959 KB

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed